Self-Attestation
My name is Wilber Huang on behalf of Abnova (Taiwan) Corporation. I understand that our customers are relying on this attestation prior to purchasing gene synthesis equipment or gene synthesis products.
My company self-attests to complying with the US Framework for Nucleic Acid Synthesis Screening.
Should the information checked above change, Abnova (Taiwan) Corporation agrees that we will provide updated information to our customers.
Signature Wilber Huang Printed name Signed on October 21, 2024 Taipei, Taiwan |
+886-2-87511888
sales@abnova.com
Abnova has established a comprehensive portfolio of fully integrated solutions to address the needs of the in vitro diagnostic (IVD) industry. Abnova provides its partners and customers access to the technologies, products, and services relating to circulating rare cells, circulating exosomes, and circulating cell-free RNA for early to metastatic to recurrent disease and treatment diagnosis, prediction, guidance, and monitoring. Abnova facility is for proprietary bioreagent and high-throughput automation development and manufacturing for clinical trials and IVD commercialization. (www.abnova.com)